-+ 0.00%
-+ 0.00%
-+ 0.00%

Chardan Capital Initiates Coverage On Vicore Pharma Holding with Buy Rating, Announces Price Target of $15

Benzinga·11/05/2026 00:26:27
Listen to the news
Chardan Capital analyst Andreas Argyrides initiates coverage on Vicore Pharma Holding (NASDAQ:VCRE) with a Buy rating and announces Price Target of $15.